222 related articles for article (PubMed ID: 34474344)
21. Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
Hu YB; Yan C; Mu L; Mi YL; Zhao H; Hu H; Li XL; Tao DD; Wu YQ; Gong JP; Qin JC
Oncogene; 2019 Mar; 38(11):1951-1965. PubMed ID: 30390075
[TBL] [Abstract][Full Text] [Related]
22. Lactobacillus plantarum-derived metabolites sensitize the tumor-suppressive effects of butyrate by regulating the functional expression of SMCT1 in 5-FU-resistant colorectal cancer cells.
Kim HJ; An J; Ha EM
J Microbiol; 2022 Jan; 60(1):100-117. PubMed ID: 34964946
[TBL] [Abstract][Full Text] [Related]
23. Patient-derived Organoid Model for Predicting the Chemoresponse in Patients With Colorectal Cancer.
Yi K; Park SH; Kim DU; Jeon DY; Lee HJ; Song GA; Jo HJ; Baek DH; Han JH; Lee BC
In Vivo; 2023; 37(4):1751-1759. PubMed ID: 37369516
[TBL] [Abstract][Full Text] [Related]
24. SUMO2/3 promotes the progression and oxaliplatin resistance of colorectal cancer through facilitating the SUMOylation at Ku80-K307.
Feng D; He J; Yuan M; Chen Q; Zeng X; Zhou Q; Wu J; Han B
Biofactors; 2023; 49(6):1158-1173. PubMed ID: 37338025
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of hnRNPAB reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells.
Zhou J; Chen S; Liu J; Du J; Li J
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165920
[TBL] [Abstract][Full Text] [Related]
26. PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil.
Schöckel L; Woischke C; Surendran SA; Michl M; Schiergens T; Hölscher A; Glass F; Kreissl P; Klauschen F; Günther M; Ormanns S; Neumann J
BMC Cancer; 2024 Feb; 24(1):234. PubMed ID: 38378472
[TBL] [Abstract][Full Text] [Related]
27. Ketogenesis attenuated KLF5 disrupts iron homeostasis via LIF to confer oxaliplatin vulnerability in colorectal cancer.
Jiang H; Zeng Y; Jiang X; Xu X; Zhao L; Yuan X; Xu J; Zhao M; Wu F; Li G
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167210. PubMed ID: 38704001
[TBL] [Abstract][Full Text] [Related]
28. KIAA1549 promotes the development and chemoresistance of colorectal cancer by upregulating ERCC2.
Ye F; Xie Y; Lin M; Liu Y; Fang Y; Chen K; Zhang Y; Ding Y
Mol Cell Biochem; 2024 Mar; 479(3):629-642. PubMed ID: 37140813
[TBL] [Abstract][Full Text] [Related]
29. MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway.
Ma D; Liu S; Liu K; Kong L; Xiao L; Xin Q; Jiang C; Wu J
Cancer Biol Ther; 2024 Dec; 25(1):2314324. PubMed ID: 38375821
[TBL] [Abstract][Full Text] [Related]
30. Engineering lauric acid-based nanodrug delivery systems for restoring chemosensitivity and improving biocompatibility of 5-FU and OxPt against
Su M; Wen X; Yu Y; Li N; Li X; Qu X; Elsabahy M; Gao H
J Mater Chem B; 2024 Apr; 12(16):3947-3958. PubMed ID: 38586917
[TBL] [Abstract][Full Text] [Related]
31. Acetylation of aldehyde dehydrogenase ALDH1L2 regulates cellular redox balance and the chemosensitivity of colorectal cancer to 5-fluorouracil.
Li C; Teng P; Sun S; Cui K; Yao S; Fei B; Ling F; Huang Z
J Biol Chem; 2023 Sep; 299(9):105090. PubMed ID: 37507016
[TBL] [Abstract][Full Text] [Related]
32. The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Combined Effect of Caffeine and 5-Fluorouracil on Colorectal Cancer Cell Lines.
Khavari F; Taheri M; Manoochehri H; Molaei P; Nouri F
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1419-1424. PubMed ID: 38680003
[TBL] [Abstract][Full Text] [Related]
34. The rational modulation of autophagy sensitizes colorectal cancer cells to 5-fluouracil and oxaliplatin.
Baldasso-Zanon A; Silva AO; Franco N; Picon RV; Lenz G; Lopez PLDC; Filippi-Chiela EC
J Cell Biochem; 2024 Feb; 125(2):e30517. PubMed ID: 38224178
[TBL] [Abstract][Full Text] [Related]
35. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution.
Chen G; Gong T; Wang Z; Wang Z; Lin X; Chen S; Sun C; Zhao W; Kong Y; Ai H; Yang H; Liu Y; Wu F; Kang J; Zhao S; Xiao X; Sun J; He A; Li Z
Cell Oncol (Dordr); 2022 Dec; 45(6):1155-1167. PubMed ID: 36136268
[TBL] [Abstract][Full Text] [Related]
36. RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity.
Morinaka T; Sakai N; Takayashiki T; Kuboki S; Takano S; Ohira G; Matsubara H; Ohtsuka M
Int J Oncol; 2023 Nov; 63(5):. PubMed ID: 37654197
[TBL] [Abstract][Full Text] [Related]
37. Colorectal Cancer-Associated Smad4 R361 Hotspot Mutations Boost Wnt/β-Catenin Signaling through Enhanced Smad4-LEF1 Binding.
Lanauze CB; Sehgal P; Hayer K; Torres-Diz M; Pippin JA; Grant SFA; Thomas-Tikhonenko A
Mol Cancer Res; 2021 May; 19(5):823-833. PubMed ID: 33608451
[TBL] [Abstract][Full Text] [Related]
38. WD repeat domain 62 (WDR62) promotes resistance of colorectal cancer to oxaliplatin through modulating mitogen-activated protein kinase (MAPK) signaling.
Cai J; Su L; Luo W
Bioengineered; 2022 Jun; 13(6):14450-14459. PubMed ID: 35758246
[TBL] [Abstract][Full Text] [Related]
39. lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin.
Wang X; Zhang H; Yin S; Yang Y; Yang H; Yang J; Zhou Z; Li S; Ying G; Ba Y
EMBO Rep; 2022 Jan; 23(1):e53140. PubMed ID: 34779552
[TBL] [Abstract][Full Text] [Related]
40. MACC1 and Gasdermin-E (GSDME) regulate the resistance of colorectal cancer cells to irinotecan.
Cheng MZ; Yang BB; Zhan ZT; Lin SM; Fang ZP; Gao Y; Zhou WJ
Biochem Biophys Res Commun; 2023 Sep; 671():236-245. PubMed ID: 37307707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
